Antithrombin III in patients with severe sepsis - A multinational, double-blind, randomized, placebo-controlled phase-III study.

被引：0
|
作者：
Opal, S
Heinrichs, H
Mescheder, A
Keinecke, HO
Knaub, S
机构：
[1] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA
[2] Centeon Pharma GMBH, Marburg, Germany
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3444
引用
收藏
页码：108B / 108B
页数：1
相关论文
共 50 条
  • [1] Antithrombin III in patients with severe sepsis - A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
    Eisele, B
    Lamy, M
    Thijs, LG
    Keinecke, HO
    Schuster, HP
    Matthias, FR
    Fourrier, F
    Heinrichs, H
    Delvos, U
    INTENSIVE CARE MEDICINE, 1998, 24 (07) : 663 - 672
  • [2] Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial
    Lamy, M
    Eisele, B
    Keinecke, HO
    Delvos, U
    Thijs, LG
    9TH EUROPEAN CONGRESS ON INTENSIVE CARE MEDICINE, 1996, : 385 - 390
  • [3] Antithrombin III in patients with severe sepsisA randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis
    B. Eisele
    H. Heinrichs
    U. Delvos
    M. Lamy
    L. G. Thijs
    H. O. Keinecke
    H. P. Schuster
    F. R. Matthias
    F. Fourrier
    Intensive Care Medicine, 1998, 24 : 663 - 672
  • [4] Pentoxifylline in severe sepsis: a double-blind, randomized placebo-controlled study
    KH Staubach
    J Schröder
    P Zabel
    F Stüber
    Critical Care, 2 (Suppl 1):
  • [5] A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
    Papp, K. A.
    Reich, K.
    Paul, C.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Langley, R. G.
    Cather, J.
    Gottlieb, A. B.
    Thaci, D.
    Krueger, J. G.
    Russell, C. B.
    Milmont, C. E.
    Li, J.
    Klekotka, P. A.
    Kricorian, G.
    Nirula, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (02) : 273 - 286
  • [6] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis
    Guntupalli, Kalpalatha
    Dean, Nathan
    Morris, Peter E.
    Bandi, Venkata
    Margolis, Benjamin
    Rivers, Emanuel
    Levy, Mitchell
    Lodato, Robert F.
    Ismail, Preeti M.
    Reese, Amber
    Schaumberg, John P.
    Malik, Rajesh
    Dellinger, R. Phillip
    CRITICAL CARE MEDICINE, 2013, 41 (03) : 706 - 716
  • [7] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Masato Murakami
    Kenichi Osada
    Hiromichi Mizuno
    Toshimitsu Ochiai
    Levent Alev
    Kusuki Nishioka
    Arthritis Research & Therapy, 17
  • [8] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [9] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Murakami, Masato
    Osada, Kenichi
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Alev, Levent
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [10] Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial
    Vahlquist, A.
    Blockhuys, S.
    Steijlen, P.
    van Rossem, K.
    Didona, B.
    Blanco, D.
    Traupe, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (01) : 173 - 181
12345